Surveillance and Epidemiology of Viral Hemorrhagic Fevers (Vhfs) : Identification of Emergence, Seroprevelance, and Risk Factors of Vhfs in Uganda Trevor Shoemaker
Total Page:16
File Type:pdf, Size:1020Kb
Surveillance and Epidemiology of Viral Hemorrhagic Fevers (VHFs) : identification of emergence, seroprevelance, and risk factors of VHFs in Uganda Trevor Shoemaker To cite this version: Trevor Shoemaker. Surveillance and Epidemiology of Viral Hemorrhagic Fevers (VHFs) : identification of emergence, seroprevelance, and risk factors of VHFs in Uganda. Human health and pathology. Université Montpellier, 2019. English. NNT : 2019MONTG044. tel-02611047 HAL Id: tel-02611047 https://tel.archives-ouvertes.fr/tel-02611047 Submitted on 18 May 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE POUR OBTENIR LE GRADE DE DOCTEUR DE L’UNIVERSITÉ DE MONTPELLIER PAR LA VALIDATION DES ACQUIS DE L’EXPÉRIENCE Année universitaire 2019-2020 En Ecologie de la santé École doctorale GAIA, Biologie des Interactions Biodiversité, Agriculture, Alimentation, Environnement, Terre, Eau Unité de recherche ASTRE, CIRAD SYNTHÈSE DES TRAVAUX DE RECHERCHE Surveillance et épidémiologie des fièvres hémorragiques virales (FHV): identification de l'émergence, de la séroprévelance et des facteurs de risque des FHV en Ouganda Présentée par Trevor SHOEMAKER Le 15 Novembre 2019 Devant le jury composé de Martine PEETERS, Directeur de Recherche, IRD, Montpellier Présidente du Jury Jean-Claude MANUGUERRA, Directeur de Recherche, Institut Pasteur Rapporteur Frederick ARNAUD, Directeur d'Etudes Cumulant, EPHE Rapporteur Raphaëlle METRAS, Chargée de Recherche Classe Normale, Inserm Examinateur Chiara POLETTO, Chargée de Recherche Classe Normale, Inserm Examinateur Catherine MOULIA, Professeur des Universités, Université de Montpellier Examinateur Mathieu SICARD, Professeur des Universités, Université de Montpellier Examinateur Thierry LEFRANÇOIS, Chercheur, CIRAD Directeur du Thèse 1 Dedication To my family Melissa, Annabelle, Caiden and Wesley i Table of Contents Dedication ............................................................................................................................................................................ i Acknowledgements ........................................................................................................................................................... iii Résumé de these ................................................................................................................................................................ v List of Figures and Tables ................................................................................................................................................. xiii List of Acronyms .............................................................................................................................................................. xiv 1 Introduction and Objectives ....................................................................................................................................... 1 2 Background ................................................................................................................................................................. 4 2.1 Epidemiology, ecology, and clinical presentation of VHFs .........................................................................4 2.1.1 Ebolaviruses ........................................................................................................................................4 2.1.2 Marburgvirus ......................................................................................................................................6 2.1.3 Crimean-Congo hemorrhagic fever virus ...........................................................................................8 2.1.4 Rift Valley fever virus ..........................................................................................................................9 2.2 VHF surveillance system in Uganda ......................................................................................................... 14 2.3 RVFV Emergence in Uganda .................................................................................................................... 16 3 Methods and Results ................................................................................................................................................ 17 3.1 Objective 1 ............................................................................................................................................... 17 3.2 Objective 2 ............................................................................................................................................... 20 3.3 Objective 3 ............................................................................................................................................... 25 3.4 Objective 4 ............................................................................................................................................... 30 3.5 Objective 5 ............................................................................................................................................... 31 3.6 Objective 6 ............................................................................................................................................... 33 3.6.1 Objective 6 Part 1 ............................................................................................................................ 34 3.6.2 Objective 6 Part 2 ............................................................................................................................ 43 3.6.3 Objective 6 Part 3 ............................................................................................................................ 46 4 Discussion ................................................................................................................................................................. 49 5 Conclusions and Perspectives .................................................................................................................................. 61 6 Personal Perspective ................................................................................................................................................ 64 7 References ................................................................................................................................................................ 65 8 Manuscripts .............................................................................................................................................................. 74 ii Acknowledgements I would like to acknowledge the following for their support and contributions to my personnel and professional growth, career, and completion of my PhD thesis. I want to thank my colleagues at CIRAD, specifically Raphaëlle Metras and Tierry Lefrançois, for their generous support, guidance and collaboration that has allowed me to complete my PhD thesis. It was Raphaëlle who in initially proposed, and then made possible, the opportunity for me to complete my PhD thesis through GAIA at the University of Montpellier. I especially want to acknowledge Lefrançois for his generous support, time to agreeing to be my primary PhD thesis advisor and supporting me through this process. I want to also thank Nathalie Vachiery and Renaud Lancelot for their generous support and collaboration from CIRAD to make this all possible. I also want to thank the staff from the University of Montpellier Institut des Sciences, especially Mathieu Sicard, for his approval of my initial PhD proposal and allowing me to begin this process. I want to thank Carole Raabon, Chef du service Validation des acquis (VAE), for helping me manage the VAE doctoral process. I also want to acknowledge my thesis jury committee for their generous contribution of time and scientific review of my PhD thesis. I will also be forever grateful to all my friends, colleagues and staff form Uganda at the Uganda Virus Research Institute (UVRI). I want to especially thank Dr Julious Lutwana and Dr Edward Mbidde for allowing me to work at the institute and their very generous support and scientific and personal guidance for helping establish the viral hemorrhagic fever surveillance and reference laboratory that contributed the majority of my professional work that makes up my PhD thesis. I want to acknowledge and thank Stephen Balinandi for his friendship and professional support and my primary colleague which made possible all the great and successful VHF work we were able to accomplish and build together since it was just the two of us! I want to especially thank Luke Nyakarahuka who started out as an eager and open-minded epidemiologist and to nobody’s surprise is now an accomplished subject matter expert and leader in the field of VHFs. Both of you have taught me more than I could ever teach you and made my work so much easier and ill carry the experience we had together with me always. I also want show my appreciation to my colleagues Tumusiime Alex, Jackson Kyondo, Sophia Mulei and Apollo